myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
NICE has developed a medtech innovation briefing (MIB) on myCOPD for self-management of chronic obstructive pulmonary disease
Search results
61 results
-
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
-
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
-
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)
Summary of the evidence on antimicrobial prescribing: delafloxacin
-
Antimicrobial prescribing: cefiderocol (ES31)
Summary of the evidence on antimicrobial prescribing: cefiderocol
-
COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)
ES34 Product overview The content of this evidence summary was up to date in January 2021. New evidence may have been
-
COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES23)
ES23 . Key messages The content of this evidence review was up to date on 24 March 2020. New evidence may have been published since
-
COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis (ES26)
ES26 . Key messages The content of this evidence review was up to date on 13 May 2020. New evidence may have been published since
-
COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)
ES27 . Key messages The content of this evidence review was up to date on 4 June 2020. New evidence has been published since then
-
COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 (ES24)
ES24 . Key messages The content of this evidence review was up to date on 1 April 2020. New evidence may have been published since
-
COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES25)
ES25 . Key messages The content of this evidence review was up to date on 20 April 2020. New evidence may have been published since
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis (ES35)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
-
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
ES33 Product overview The content of this evidence summary was up to date in February 2021. New evidence may have been
-
Actim Pancreatitis for diagnosing acute pancreatitis (MIB218)
NICE has developed a medtech innovation briefing (MIB) on Actim Pancreatitis for diagnosing acute pancreatitis
-
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic (MIB219)
NICE has developed a medtech innovation briefing (MIB) on CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic
-
Prontosan for acute and chronic wounds (MIB220)
NICE has developed a medtech innovation briefing (MIB) on Prontosan for acute and chronic wounds
-
Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)
NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio
-
pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms (MIB222)
NICE has developed a medtech innovation briefing (MIB) on pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms
-
Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome (MIB223)
NICE has developed a medtech innovation briefing (MIB) on Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome
-
Dexcom G6 for real-time continuous glucose monitoring (MIB233)
NICE has developed a medtech innovation briefing (MIB) on Dexcom G6 for real-time continuous glucose monitoring
-
ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections (MIB234)
NICE has developed a medtech innovation briefing (MIB) on ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream
-
NPi-200 for pupillary light reflex in critical care patients (MIB235)
NICE has developed a medtech innovation briefing on NPi-200 for pupillary light reflex in critical care patients
-
Magseed for locating impalpable breast cancer lesions (MIB236)
NICE has developed a medtech innovation briefing on Magseed for locating impalpable breast cancer lesions
-
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
NICE has developed a medtech innovation briefing (MIB) on QuickChange Incontinence Wrap for urinary incontinence in men
-
Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain (MIB238)
NICE has developed a medtech innovation briefing (MIB) on Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
-
ReStore Soft Exo-Suit for gait rehabilitation (MIB239)
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation
-
AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)
NICE has developed a medtech innovation briefing (MIB) on AnaConDa-S for sedation with volatile anaesthetics in intensive care
-
3C Patch System for treating diabetic foot ulcers (MIB230)
NICE has developed a medtech innovation briefing (MIB) on 3C Patch System for treating diabetic foot ulcers
-
Tegaderm CHG securement dressing for vascular access sites (MIB231)
NICE has developed a medtech innovation briefing (MIB) on Tegaderm CHG securement dressing for vascular access sites
-
KardiaMobile for the ambulatory detection of atrial fibrillation (MIB232)
NICE has developed a medtech innovation briefing (MIB) on KardiaMobile for the ambulatory detection of atrial fibrillation
-
FebriDx for C-reactive protein and myxovirus resistance protein A testing (MIB224)
NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing
-
Helge for detecting haemolysis (MIB225)
NICE has developed a medtech innovation briefing (MIB) on Helge for detecting haemolysis
-
Synergo for non-muscle-invasive bladder cancer (MIB226)
NICE has developed a medtech innovation briefing (MIB) on Synergo for non-muscle-invasive bladder cancer
-
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)
NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes
-
Novii Wireless Patch System for maternal and fetal monitoring (MIB228)
NICE has developed a medtech innovation briefing (MIB) on Novii Wireless Patch System for maternal and fetal monitoring
-
Artificial intelligence for analysing CT brain scans (MIB207)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans
-
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wound
-
EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules (MIB209)
NICE has developed a medtech innovation briefing (MIB) on EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules
-
Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)
NICE has developed a medtech innovation briefing (MIB) on faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection.
-
DOAC Dipstick for detecting direct oral anticoagulants (MIB248)
NICE has developed a medtech innovation briefing (MIB) on DOAC Dipstick for detecting direct oral anticoagulants
-
CytoSorb for reducing risk of bleeding during cardiac surgery (MIB249)
NICE has developed a medtech innovation briefing (MIB) on CytoSorb for reducing risk of bleeding during cardiac surgery
-
URO17 for detecting bladder cancer (MIB250)
NICE has developed a medtech innovation briefing (MIB) on URO17 for detecting bladder cancer
-
Accuro for guiding epidural or spinal anaesthesia (MIB245)
NICE has developed a medtech innovation briefing (MIB) on Accuro for guiding epidural or spinal anaesthesia
-
AcQMap for mapping the heart atria to target ablation treatment for arrhythmias (MIB246)
NICE has developed a medtech innovation briefing (MIB) on AcQMap for mapping the heart atria to target ablation treatment for arrhythmias
-
Cytosponge for detecting abnormal cells in the oesophagus (MIB240)
NICE has developed a medtech innovation briefing (MIB) on Cytosponge for detecting abnormal cells in the oesophagus
-
The STAK tool for preventing and treating knee stiffness (MIB252)
NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness
-
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)
NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery
-
moorLDLS-BI for burn depth assessment (MIB251)
NICE has developed a medtech innovation briefing (MIB) on moorLDLS-BI for burn depth assessment
-
Natural Cycles for monitoring fertility (MIB244)
NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility
-
Artificial intelligence in mammography (MIB242)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography